TIGECYCLINE INTAS tigecycline 50 mg powder for injection vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
11-04-2021

유효 성분:

tigecycline, Quantity: 50 mg

제공처:

Accord Healthcare Pty Ltd

약제 형태:

Injection, powder for

구성:

Excipient Ingredients: maltose; hydrochloric acid; sodium hydroxide

관리 경로:

Intravenous

패키지 단위:

1, 10

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

TIGECYCLINE INTAS is indicated for the treatment of the following infections in adults:,Complicated skin and skin structure infections, including those with methicillin-resistant Staphylococcus aureus (MRSA), where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.,Complicated intra-abdominal infections, where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.

제품 요약:

Visual Identification: Orange powder or cake; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Registered

승인 날짜:

2021-02-11